Anna Jonasova
AuthID: R-00F-H5Y
1
TITLE: Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stefanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Alberto Risueno; Kyle J MacBeth; Jianhua H Zhong; Francis Seguy; Albert Hoenekopp; ...More
PUBLISHED: 2016, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 25
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stefanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Alberto Risueno; Kyle J MacBeth; Jianhua H Zhong; Francis Seguy; Albert Hoenekopp; ...More
PUBLISHED: 2016, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 25
2
TITLE: Safety of Lenalidomide (LEN) 10mg in Non-Del(5q) Versus Del(5q) in the Treatment of Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (MDS): Pooled Analysis of Treatment-Emergent Adverse Events (TEAEs)
AUTHORS: Antonio Almeida; Valeria Santini; Stefanie Croepper; Anna Jonasova; Norbert Vey; Aristoteles Giagounidis; Eva Hellstrom Lindberg; Ghulam J Mufti; Guillermo Sanz; Barry Skikne; Albert Hoenekopp; Francis Seguy; Jianhua H Zhong; Pierre Fenaux;
PUBLISHED: 2015, SOURCE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, ISSUE: 23
AUTHORS: Antonio Almeida; Valeria Santini; Stefanie Croepper; Anna Jonasova; Norbert Vey; Aristoteles Giagounidis; Eva Hellstrom Lindberg; Ghulam J Mufti; Guillermo Sanz; Barry Skikne; Albert Hoenekopp; Francis Seguy; Jianhua H Zhong; Pierre Fenaux;
PUBLISHED: 2015, SOURCE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, ISSUE: 23
INDEXED IN: 
WOS
WOS3
TITLE: Efficacy and Safety of Lenalidomide (LEN) Versus Placebo (PBO) in RBC-Transfusion Dependent (TD) Patients (Pts) with IPSS Low/Intermediate (Int-1)-Risk Myelodysplastic Syndromes (MDS) without Del(5q) and Unresponsive or Refractory to Erythropoiesis-Stimulating Agents (ESAs): Results from a Randomized Phase 3 Study (CC-5013-MDS-005)
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stephanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Jim Zhong; Francis Seguy; Albert Hoenekopp; Beach, CL; Pierre Fenaux;
PUBLISHED: 2014, SOURCE: 56th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 124, ISSUE: 21
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stephanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Jim Zhong; Francis Seguy; Albert Hoenekopp; Beach, CL; Pierre Fenaux;
PUBLISHED: 2014, SOURCE: 56th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 124, ISSUE: 21
INDEXED IN: WOS
WOS